Is Spinal Muscular Atrophy hereditary?

Spinal Muscular Atrophy (SMA) is a hereditary genetic condition caused by mutations in the SMN1 gene, which follows an autosomal recessive inheritance pattern. This means that both parents must typically be carriers of a non-working gene copy to pass the condition to their child, resulting in a 25% chance of recurrence for each pregnancy.

Is Spinal Muscular Atrophy hereditary and how is it passed down?

Spinal Muscular Atrophy is strictly a genetic and hereditary condition. It is "genetic" because it is caused by mutations in DNA, and "hereditary" because these mutations are passed from parents to offspring. The condition follows an autosomal recessive inheritance pattern. In this pattern, an individual must inherit two copies of the mutated gene—one from each parent—to manifest Spinal Muscular Atrophy. Carriers, who possess only one mutated copy of the SMN1 gene, generally do not exhibit symptoms of the disease.

What is the risk of recurrence for families?

When both parents are identified as carriers of Spinal Muscular Atrophy, the statistical probability for each pregnancy is as follows:

• 25% chance that the child will have Spinal Muscular Atrophy (inheriting the mutation from both parents).


• 50% chance that the child will be an asymptomatic carrier (inheriting one mutation).


• 25% chance that the child will not have the mutation and will not be a carrier.

It is important to note that de novo (spontaneous) mutations are rare in Spinal Muscular Atrophy; the vast majority of cases are inherited from carrier parents. While there is a very small percentage of cases (approximately 2%) where a new mutation occurs in the germline or early development, family history remains the most significant factor in risk assessment.

How is genetic testing and counseling utilized?

Genetic testing for Spinal Muscular Atrophy is highly accurate and is now standard practice in many newborn screening programs worldwide. The test typically involves a blood sample to look for the deletion or mutation of the SMN1 gene. For families with a history of the disease, genetic counseling is a vital step during family planning. Counselors help parents understand their carrier status and explore reproductive options, such as Preimplantation Genetic Testing (PGT) alongside In Vitro Fertilization (IVF) or prenatal diagnostic testing (like chorionic villus sampling or amniocentesis).

Next steps

• Consult with a clinical geneticist or a genetic counselor to review your family history and determine if carrier testing is appropriate for you and your partner.


• If you are expecting, discuss newborn screening options for Spinal Muscular Atrophy with your obstetrician or pediatrician.


• Connect with the 972 members of the Spinal Muscular Atrophy community at DiseaseMaps.org to share experiences and find support.


• Visit the NIH Genetic and Rare Diseases (GARD) Information Center for up-to-date resources on diagnostic testing and clinical trial eligibility.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Spinal Muscular Atrophy.


• Orphanet: Spinal Muscular Atrophy (ORPHA:83390).


• OMIM (Online Mendelian Inheritance in Man): Survival Motor Neuron 1; SMN1 (#601627).


• Cure SMA: Understanding Genetics and Inheritance.